Dudley & Shanley’s Covetrus, Inc. Common Stock CVET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-788,655
Closed -$14.3M 39
2021
Q3
$14.3M Buy
788,655
+245,430
+45% +$5.63M 2.52% 19
2021
Q2
$14.7M Buy
543,225
+3,050
+0.6% +$85.3K 2.42% 20
2021
Q1
$16.2M Buy
540,175
+9,425
+2% +$321K 2.79% 18
2020
Q4
$15.3M Buy
+530,750
New +$14.3M 2.81% 18

Other funds holding CVET

Dudley & Shanley's CVET Position: Q4 2021 in Review

Dudley & Shanley sold out of Covetrus, Inc. Common Stock (CVET) in Q4 2021, closing a stake of 788,655 shares — an estimated $14.3M sold.

Dudley & Shanley first reported a position in CVET in Q4 2020 and held it in 4 quarters. The position peaked at $16.2M in Q1 2021. 246 funds tracked by Wall St. Rank hold CVET as of Q4 2021.

  • Dudley & Shanley reported no remaining Covetrus, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • Dudley & Shanley sold 788,655 Covetrus, Inc. Common Stock shares in Q4 2021, an estimated $14.3M.
  • Dudley & Shanley first reported a position in Covetrus, Inc. Common Stock in Q4 2020 and held it in 4 quarters.
  • Dudley & Shanley's Covetrus, Inc. Common Stock position peaked at $16.2M in Q1 2021.
  • 246 funds tracked by Wall St. Rank held Covetrus, Inc. Common Stock as of Q4 2021.

Based on Dudley & Shanley's 13F filing for Q4 2021, filed 18 Jan 2022.